Tampilan Petugas: Analysis of the Restriction of Vancomycin Use in Hospitals Before, During and After the Implementation of the Antimicrobial Resistance Control Program (ARCP)

Analysis of the Restriction of Vancomycin Use in Hospitals Before, During and After the Implementation of the Antimicrobial Resistance Control Program (ARCP)

Main Authors:	Wardoyo, Eustachius Hagni, Yudhanto, Didit, Asmara, I Gede Yasa, Salsabila, Claresta, Retno, Ajeng
Format:	Article info application/pdf eJournal
Bahasa:	eng
Terbitan:	Rumah Sakit Penyakit Infeksi Prof Dr. Sulianti Saroso , 2020
Subjects:	Antimicrobial Resistance Control Program vancomycin restriction policy
Online Access:	https://www.ijid-rspisuliantisaroso.co.id/index.php/ijid/article/view/109 https://www.ijid-rspisuliantisaroso.co.id/index.php/ijid/article/view/109/pdf

ctrlnum	article-109
fullrecord	<?xml version="1.0"?> <dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><title lang="en-US">Analysis of the Restriction of Vancomycin Use in Hospitals Before, During and After the Implementation of the Antimicrobial Resistance Control Program (ARCP)</title><creator>Wardoyo, Eustachius Hagni</creator><creator>Yudhanto, Didit</creator><creator>Asmara, I Gede Yasa</creator><creator>Salsabila, Claresta</creator><creator>Retno, Ajeng</creator><subject lang="en-US">Antimicrobial Resistance Control Program</subject><subject lang="en-US">vancomycin restriction policy</subject><description lang="en-US">Background: A policy restricting the use of vancomycin was a pilot project for the implementation of the Antimicrobial Resistance Control Program (ARCP) in RSUD Nusa Tenggara Barat in 2018. There were three phases of the ARCP in hospitals, namely preparation, execution, and monitoring. This research aimed to evaluate the quality of vancomycin prescribing before, during, and after the implementation of ARCP in 2017â€“2019. Method: Descriptive analysis was conducted of all the vancomycin prescriptions before, during, and after the implementation of ARCP in 2018. All medical records of cases requiring vancomycin prescriptions during the research period was evaluated: patient characteristics, culture test results, and clinical diagnoses. The quality of vancomycin prescriptions, which was expressed as follows: â€œVancomycin prescriptions are intended only for infections caused by Gram-positive pathogens, particularly Staphylococcus aureus, that are resistant to methicillin (MRSA), Enterococcus sp (Vancomycin-sensitive enterococci)â€ was evaluated. Results: There were sixty-one cases of vancomycin prescribing; 21 female and 40 male patients, with a mean age of 23 years (0â€“82 years). Overall, there were 41 positive cultures, 5 negative cultures, and 15 no-cultures. The diagnoses were moderate to severe infections: sepsis, pneumonia, post-surgery infections, CNS infections, low birth weight, septic shocks, and chronic obstructive lung diseases. The urinary tract infection was present as a mild infection. The prescription quality indicators â€˜vancomycin is prescribed only for moderate to severe infectionsâ€™ and â€˜prescribed only for Gram-positive pathogensâ€™ altogether increased. Conclusion: There was improvement in the vancomycin prescription quality after the implementation of the vancomycin restriction policy.</description><publisher lang="en-US">Rumah Sakit Penyakit Infeksi Prof Dr. Sulianti Saroso</publisher><date>2020-12-30</date><type>Journal:Article</type><type>Other:info:eu-repo/semantics/publishedVersion</type><type>Journal:Article</type><type>File:application/pdf</type><identifier>https://www.ijid-rspisuliantisaroso.co.id/index.php/ijid/article/view/109</identifier><identifier>10.32667/ijid.v6i2.109</identifier><source lang="en-US">The Indonesian Journal of Infectious Diseases; Vol. 6 No. 2 (2020): The Indonesian Journal of Infectious Disease; 1-8</source><source>2599-1698</source><source>2354-6077</source><source>10.32667/ijid.v6i2</source><language>eng</language><relation>https://www.ijid-rspisuliantisaroso.co.id/index.php/ijid/article/view/109/pdf</relation><rights lang="en-US">Copyright (c) 2020 The Indonesian Journal of Infectious Diseases</rights><recordID>article-109</recordID></dc>
language	eng
format	Journal:Article Journal Other:info:eu-repo/semantics/publishedVersion Other File:application/pdf File Journal:eJournal
author	Wardoyo, Eustachius Hagni Yudhanto, Didit Asmara, I Gede Yasa Salsabila, Claresta Retno, Ajeng
title	Analysis of the Restriction of Vancomycin Use in Hospitals Before, During and After the Implementation of the Antimicrobial Resistance Control Program (ARCP)
publisher	Rumah Sakit Penyakit Infeksi Prof Dr. Sulianti Saroso
publishDate	2020
topic	Antimicrobial Resistance Control Program vancomycin restriction policy
url	https://www.ijid-rspisuliantisaroso.co.id/index.php/ijid/article/view/109 https://www.ijid-rspisuliantisaroso.co.id/index.php/ijid/article/view/109/pdf
contents	Background: A policy restricting the use of vancomycin was a pilot project for the implementation of the Antimicrobial Resistance Control Program (ARCP) in RSUD Nusa Tenggara Barat in 2018. There were three phases of the ARCP in hospitals, namely preparation, execution, and monitoring. This research aimed to evaluate the quality of vancomycin prescribing before, during, and after the implementation of ARCP in 2017â€“2019. Method: Descriptive analysis was conducted of all the vancomycin prescriptions before, during, and after the implementation of ARCP in 2018. All medical records of cases requiring vancomycin prescriptions during the research period was evaluated: patient characteristics, culture test results, and clinical diagnoses. The quality of vancomycin prescriptions, which was expressed as follows: â€œVancomycin prescriptions are intended only for infections caused by Gram-positive pathogens, particularly Staphylococcus aureus, that are resistant to methicillin (MRSA), Enterococcus sp (Vancomycin-sensitive enterococci)â€ was evaluated. Results: There were sixty-one cases of vancomycin prescribing; 21 female and 40 male patients, with a mean age of 23 years (0â€“82 years). Overall, there were 41 positive cultures, 5 negative cultures, and 15 no-cultures. The diagnoses were moderate to severe infections: sepsis, pneumonia, post-surgery infections, CNS infections, low birth weight, septic shocks, and chronic obstructive lung diseases. The urinary tract infection was present as a mild infection. The prescription quality indicators â€ ̃vancomycin is prescribed only for moderate to severe infectionsâ€TM and â€ ̃prescribed only for Gram-positive pathogensâ€TM altogether increased. Conclusion: There was improvement in the vancomycin prescription quality after the implementation of the vancomycin restriction policy.
id	IOS20143.article-109
institution	RSPI Sulianti Saroso Jakarta
institution_id	10818
institution_type	library:special library
library	Diklat Sulianti Saroso
library_id	8009
collection	The Indonesian Journal of Infectious Disease
repository_id	20143
subject_area	Kesehatan masyarakat Penyakit Infeksi
city	JAKARTA UTARA
province	DKI JAKARTA
repoId	IOS20143
first_indexed	2024-06-13T07:59:52Z
last_indexed	2024-06-13T07:59:52Z
recordtype	dc
_version_	1801734881186676736
score	9.9049015

Analysis of the Restriction of Vancomycin Use in Hospitals Before, During and After the Implementation of the Antimicrobial Resistance Control Program (ARCP)

Lihat Juga